EyeRising and Sky-n1201 reached ANSI group 1 limits within exposure times of 2.8 and 1.4 seconds for a 7-mm pupil.

RevitalEyes Optometry expands children’s eye care services to help families address progressive myopia with early ...

Fluctuating vision is the most frequently cited complaint, exceeding classic discomfort symptoms, and may divert patients toward refractive explanations before DED is recognized and treated.

FDA authorization under an IND permits first-in-human phase I/II testing of SVT-001 in familial drusen, focusing on safety ...

A newly identified protein may hold the key to preventing diabetic blindness. Researchers discovered that LRG1 triggers the ...

The primary applications of virtual reality in ophthalmology include physician and patient education, diagnostic testing in ...

As red-light laser therapy gains popularity in Asia for slowing myopia in children, reports of vision damage have emerged, ...

Gene therapies have the potential to cure some diseases, but they are extraordinarily expensive. Location can also be a big ...

Vision changes can happen for a number of reasons, some of which are no major cause for concern, such as dry eye or fatigue. But others are serious enough to warrant a trip to the emergency department ...

ROCHESTER, N.Y. (WROC) — Cornerstone Eye Associates has become the first practice in Rochester to offer Valeda Light Therapy for the treatment of dry macular degeneration. The new Food and Drug ...

The US Food and Drug Administration (FDA) has approved a Phase 1 clinical trial from Life Biosciences that aims to help certain eye cells act younger and improve vision in glaucoma and related ...